Literature DB >> 19636580

Bax-gene transfer enhances apoptosis by steroid treatment in human nasal fibroblasts.

Yuichi Kimura1, Chizuru Sugimoto, Tetsuji Takabayashi, Takeshi Tanaka, Akihiro Kojima, Norihiko Narita, Shigeharu Fujieda.   

Abstract

Gene therapy has become a focus not only in the study of cancer but also lifestyle-related diseases. In case of chronic rhinosinusitis with nasal polyps and aspirin-induced asthma, nasal polyps poorly respond to a local administration of steroid. The Bax and Bcl-2 proteins play important roles in the regulation of apoptosis. The treatment of steroid (prednisone) induced apoptosis in the fibroblast. The Bax accelerates apoptosis. Apoptosis is very important in the anti-inflammatory mechanism. In this study, we investigated whether the overexpression of Bax in human fibroblasts influences apoptosis by treatment with a steroid (prednisolone) in vitro. Human nasal fibroblasts were isolated from small pieces of nasal polyp and were transfected with a bax gene-bearing mammalian expression vector. Human nasal fibroblasts were transiently transfected with the expression vector hBaxpcDNA3 (Bax-NF) or native pcDNA3 (Neo-NF). Both transfectants (Bax-NF, Neo-NF) and wild-type-nasal fibroblast (wt-NF) were cultured in conditioning medium and treated with each concentration of prednisolone for 72 h. Prednisolone at a concentration of 10 ng/ml decreased the viability of Bax-NF compared to that of Bax-NF in the absence of prednisolone. The cytotoxicity of prednisolone to Bax-NF was significantly higher than that to Neo-NF or wt-NF (p < 0.01) and the susceptibility of Bax-NF to prednisolone was about 1,000 times that of Neo-NF or wt-NF. We found that the transfer of the exogenous bax gene enhanced the induction of apoptosis by steroid-treatment in human nasal fibroblasts. Therefore, we suggest that exogenous Bax protein expression by gene transfer might be useful for the treatment of nasal polyps. We will further the preclinical study in improving steroids dose and in adopting to transfer bax gene to the nasal polyps by intranasal injection, thus providing a more effective and safer way for the nasal polyps that poorly respond to a local administration of steroids.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19636580     DOI: 10.1007/s00405-009-1053-1

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  28 in total

Review 1.  Nasal polyps and sinusitis.

Authors:  Raymond G Slavin
Journal:  Clin Allergy Immunol       Date:  2002

2.  GRbeta expression in nasal polyp inflammatory cells and its relationship to the anti-inflammatory effects of intranasal fluticasone.

Authors:  D L Hamilos; D Y Leung; S Muro; A M Kahn; S S Hamilos; S E Thawley; Q A Hamid
Journal:  J Allergy Clin Immunol       Date:  2001-07       Impact factor: 10.793

3.  Combined nasal challenge with diesel exhaust particles and allergen induces In vivo IgE isotype switching.

Authors:  S Fujieda; D Diaz-Sanchez; A Saxon
Journal:  Am J Respir Cell Mol Biol       Date:  1998-09       Impact factor: 6.914

4.  Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor beta-isoform.

Authors:  A R Sousa; S J Lane; J A Cidlowski; D Z Staynov; T H Lee
Journal:  J Allergy Clin Immunol       Date:  2000-05       Impact factor: 10.793

Review 5.  Update on gene therapy approaches for cancer.

Authors:  Monika Wierdl; Philip M Potter
Journal:  Curr Hematol Rep       Date:  2005-07

6.  Eosinophilic apoptosis in sinus mucosa: relationship to tissue eosinophilia and its resolution in allergic sinusitis.

Authors:  G K Fan; T Itoh; M Imanaka; S Fujieda; H Takenaka
Journal:  J Allergy Clin Immunol       Date:  2000-09       Impact factor: 10.793

7.  N-terminal deletion augments the cell-death-inducing activity of BAX in adenoviral gene delivery to nonsmall cell lung cancers.

Authors:  Kazuhiro Usui; Yasuo Saijo; Ko Narumi; Shohei Koyama; Makoto Maemondo; Toshiaki Kikuchi; Ryushi Tazawa; Koichi Hagiwara; Yoshitomo Ishibashi; Shigeo Ohta; Toshihiro Nukiwa
Journal:  Oncogene       Date:  2003-05-01       Impact factor: 9.867

8.  The pathogenesis of nasal polyposis by immunoglobulin E and interleukin-5 is completed by transforming growth factor-beta1.

Authors:  Andor Hirschberg; Adrienn Jókúti; Zsuzsa Darvas; Krisztina Almay; Gábor Répássy; András Falus
Journal:  Laryngoscope       Date:  2003-01       Impact factor: 3.325

9.  GM-CSF, IL-5 and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis (NP).

Authors:  D L Hamilos; D Y Leung; D P Huston; A Kamil; R Wood; Q Hamid
Journal:  Clin Exp Allergy       Date:  1998-09       Impact factor: 5.018

10.  Bcl-2+ tonsillar plasma cells are rescued from apoptosis by bone marrow fibroblasts.

Authors:  P Merville; J Déchanet; A Desmoulière; I Durand; O de Bouteiller; P Garrone; J Banchereau; Y J Liu
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

View more
  2 in total

1.  Dexamethasone Induces Apoptosis of Nasal Polyp-Derived Tissue Cultures Through JNK and p38 MAPK Activation.

Authors:  Tae-Hoon Lee; Jung Gwon Nam; Ho Min Lee; Bo-Young Kim; Myung-Koo Kang; Woo Yong Bae; Dae Young Hur; Seong Kook Park
Journal:  Clin Exp Otorhinolaryngol       Date:  2014-05-21       Impact factor: 3.372

2.  Apoptosis in eosinophilic nasal polyps treated in vitro with mitomycin C.

Authors:  Cláudia Pena Galvão dos Anjos; Anilton Cesar Vasconcelos; Paulo Fernando Tormin Borges Crosara; Gustavo Coelho dos Anjos; Celso Gonçalves Becker; Roberto Eustáquio Santos Guimarães
Journal:  Braz J Otorhinolaryngol       Date:  2012-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.